Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;2(12):100250.
doi: 10.1016/j.jtocrr.2021.100250. Epub 2021 Dec 18.

Reply to K. Takada et al

Madison Ballman  1 , Cristina Mullenix  1 , Eva Szabo  1   2 , Seth M Steinberg  3 , Arun Rajan  1
Affiliations

Reply to K. Takada et al

Madison Ballman et al. JTO Clin Res Rep. 2021 Dec.
No abstract available

PubMed Disclaimer

References

    1. Takada K., Takamori S., Miura N., et al. Correspondence regarding “tolerability of coronavirus disease 2019 vaccines, BNT162b2 and mRNA-1273, in patients with thymic epithelial tumors”. JTO Clin Res Rep. 2021;2:100238. - PMC - PubMed
    1. Ballman M., Swift S., Mullenix C., et al. Tolerability of coronavirus disease 2019 vaccines, BNT162b2 and mRNA-1273, in patients with thymic epithelial tumors. JTO Clin res rep. 2021;2:100229. - PMC - PubMed
    1. Nelli F, Fabbri A, Onorato A, et al. Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective Vax-On study [e-pub ahead of print]. Ann Oncol. 10.1016/j.annonc.2021.09.009, Accessed October 21, 2021. - DOI - PMC - PubMed
    1. Nishino M, Hatabu H, Ricciuti B, Vaz V, Michael K, Awad MM. Axillary lymphadenopathy after coronavirus disease 2019 vaccinations in patients with thoracic malignancy: incidence, predisposing factors, and imaging characteristics [e-pub ahead of print]. J Thorac Oncol. https://doi.org/10.1016/j.jtho.2021.08.761, Accessed October 21, 2021. - DOI - PMC - PubMed
    1. US Food and Drug Administration. Emergency use authorization (EUA) for an unapproved product: review memorandum. Pfizer-BioNTech. COVID-19 vaccine/ BNT162b2. https://www.fda.gov/media/144416/download. Accessed October 10, 2021.